Skip to main content
Virulence logoLink to Virulence
editorial
. 2016 Jan 19;7(3):211–213. doi: 10.1080/21505594.2016.1142641

Gray phenotype: Enhanced fitness strategy for Candida dubliniensis?

Eva Pericolini 1, Elena Gabrielli 1
PMCID: PMC4871631  PMID: 26786843

Candida albicans is an opportunistic human pathogen that has been defined as a “skilled transformer” for its elevated plasticity in developing distinct forms of growth associated to a virulence program that is fully committed to escape from host immunity.1 A major component of the above plasticity is the white-opaque phenomenon, first described by David Soll's research group in a classic paper published in 1987.2 The white-opaque switch is the spontaneous generation of opaque colonies, consisting of slightly elongated cells, from the well-known white colonies of typic yeast cells. This switch is essential for fungal mating and is closely linked to hyphal transition, biofilm formation and secreted aspartyl proteinases (Sap) production, 3 significant interrelated and critical features of C. albicans virulence program. Recently, Tao L. et al 3 have discovered an independent and stable colony variant in C. albicans, called the gray phenotype, consisting in cells elongated but smaller than white and opaque cells, thus collectively forming a tristable white-gray-opaque phenotype. Gray cells of C. albicans are more virulent than white and opaque cells in models of mucosal infections.3 Many studies have demonstrated that different cell types evolved to adapt to different host niches.3-5

No surprise, the high genetic similarity between C. albicans and C. dubliniensis anticipated a similar phenotypic switch phenomenon in the latter, that in fact has now been described by Yue H. et al in this issue of Virulence.6

In this Editorial, we will focus on the possible role of gray phenotype of C. dubliniensis as a new strategy of this fungus to survive, grow and manifest its virulence in selected host niche, comparing it with the gray cells of C. albicans. The possible role of gray cells of C. dubliniensis as a mechanism evolved by this fungus to escape immune response at mucosal surfaces and grow undisturbed in the oral cavity of HIV-positive patients is discussed.

Although C. dubliniensis is much less virulent and less prevalent than C. albicans 7, its importance as a pathogen is linked to its primary association with oral colonization and infection in human immunodeficiency virus (HIV)-positive patients, causing in these patients recurrent infections.8

Gray cells of C. dubliniensis are similar to their counterparts in C. albicans in terms of several biological aspects including cellular morphology, mating competence and genetic regulatory mechanisms.6 However, the gray phenotypes of the 2 species have some distinguishing features which may contribute to explain the colonization of a specific oral niche by C. dubliniensis and conversely the easier adaptation of C. albicans to most host tissues.

Yue H. et al 6 show that while the gray phenotype of C. dubliniensis is fostered by the combined use of N-Acetylglucosammine (GlcNAc) and CO2 while the opaque phenotype is favored in C. albicans under the above conditions. Given that commensal bacteria release in the oral cavity GlcNAc and CO2, the switch to the gray phenotype could help C. dubliniensis to compete with bacterial members and C. albicans itself, for colonizing this preferred biological niche. This could explain why C. dubliniensis is primarily associated with oral colonization and infection in HIV-positive patients.

Yue H. et al 6 also pinpoint a perhaps major difference between the switching phenomena in the 2 Candida species i.e. the differential expression profile and activity of Sap, a family of enzymes with increasing evidence for a master pathogenicity role in mucosal, particularly vaginal, candidiasis. These authors show that Sap activity is induced by the protein bovine serum albumin (BSA) in gray cells of C. albicans but not in the gray cells of C. dubliniensis. Moreover, the expression level of SAP2 gene, a dominant member of Sap family in mucosal infection, is increased thousand times in the presence of BSA in gray cells of C. albicans but not in the gray cells of C. dubliniensis. Finally, in a model of mucosal infection, gray cells grow faster than white and opaque cells of C. albicans but not in C. dubliniensis.3 Overall, the above differences support the notion of a higher virulence of C. albicans as compared to C. dubliniensis.

Interestingly, Sap, in particular Sap2, has recently been shown to be responsible for the pathogenic inflammation typically associated to vaginal candidiasis in a mouse model.9 NLRP3 inflammasome activation with high production of inflammasome-dependent IL-1β and neutrophils recruitment are a landmark of this experimental vaginitis. Interestingly, C. dubliniensis is rarely if ever found in the human vagina. In contrast, NLRP3 inflammasome activity appears to be a protective mechanism against oral candidiasis 10,11, hence the observation that the gray cells of C. dubliniensis are less inflammatory at mucosal levels as compared to C. albicans would suggest that the development of the gray phenotype help C. dubliniensis avoid recognition by host protective inflammation. These speculations should be taken cautiously, however, given the complexity of functions exerted by the members of Sap family, their redundancy and relation with other virulence traits of both C. albicans and C. dubliniensis. Overall, why C. dubliniensis is so fit for oral cavity of HIV subjects remains a subject to be further investigated.

Yue H. et al 6 also report that at least 9 genes involved in ergosterol biosynthesis and 3 mannanbiosyntesis-related genes were up-regulated in gray cells of C. dubliniensis. These genes play a critical role in the regulation of antifungal resistance and other stresses. It has been suggested that C. dubliniensis is more capable of developing antifungal resistance (e.g. to azoles) than C. albicans.7,12,13 Again, this feature of C. dubliniensis may be associated with its prevalence in AIDS patients, who are often subjected to antifungal treatments with resistance outbreaks.

Yue H. et al 6 through their innovative findings have attempted to rise the attention to a new phenotype of the pathogenic fungus C. dubliniensis: the gray cells. This adds new knowledge on pathogenicity of this fungus and may help to explain its prevalence in HIV-patients subjected to antifungal treatments.

While in-depth mechanisms relating the gray phenotype to the biology and pathogenicity of C. dubliniensis are awaiting further studies, this report by Yue H. et al 6 recalls our attention to C. dubliniensis as a special pathogen in search for a specific place in the biology and pathogenicity of Candida species and its separation from C. albicans.14

Disclosure of potential conflicts of interest

No potential conflicts of interest were disclosed.

References

  • [1].Cassone A. Development of vaccines for Candida albicans: fighting a skilled transformer. Nat Rev Microbiol 2013; 11:884-91; PMID:24232568; http://dx.doi.org/ 10.1038/nrmicro3156 [DOI] [PubMed] [Google Scholar]
  • [2].Slutsky B, Staebell M, Anderson J, Risen L, Pfaller M, Soll DR. White-opaque transition: a second high-frequency switching system in Candida albicans. Journal of Bacteriology 1987; 169(1):189-97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Tao L, Du H, Guan G, Dai Y, Nobile CJ, Liang W, Cao C, Zhang Q, Zhong J, Huang G. Discovery of a “white-gray-opaque” tristable phenotypic switching system in candida albicans: roles of non-genetic diversity in host adaptation. PLoS Biol 2014; 12:e1001830; PMID:24691005; http://dx.doi.org/ 10.1371/journal.pbio.1001830 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Soll DR. The role of phenotypic switching in the basic biology and pathogenesis of Candida albicans. J Oral Microbiol 2014; 6; PMID:24455104; http://dx.doi.org/ 10.3402/jom.v6.22993 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Pande K, Chen C, Noble SM. Passage through the mammalian gut triggers a phenotypic switch that promotes Candida albicans commensalism. Nat Genet 2013; 45:1088-91; PMID:23892606; http://dx.doi.org/ 10.1038/ng.2710 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Yue H, HJ, Guan G, Tao L, Du H, Li H, Huang G.. Discovery of the gray phenotype and white-gray-opaque tristable phenotypic transition in Candida dubliniensis. Virulence 2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Ells R, Kock JL, Pohl CH. Candida albicans or Candida dubliniensis? Mycoses 2011; 54(1):1-16; PMID:19682314; http://dx.doi.org/ 10.1111/j.1439-0507.2009.01759.x [DOI] [PubMed] [Google Scholar]
  • [8].Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141 (Pt 7):1507-21; PMID:7551019; http://dx.doi.org/ 10.1099/13500872-141-7-1507 [DOI] [PubMed] [Google Scholar]
  • [9].Pericolini E, Gabrielli E, Amacker M, Kasper L, Roselletti E, Luciano E, Sabbatini S, Kaeser M, Moser C, Hube B, et al.. Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice. MBio 2015; 6:e00724; PMID:26037125; http://dx.doi.org/ 10.1128/mBio.00724-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell host & microbe 2009; 5:487-97; PMID:19454352; http://dx.doi.org/ 10.1016/j.chom.2009.05.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Naglik JR, Richardson JP, Moyes DL. Candida albicans pathogenicity and epithelial immunity. PLoS pathogens 2014; 10:e1004257; PMID:25121985; http://dx.doi.org/ 10.1371/journal.ppat.1004257 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Jackson AP, Gamble JA, Yeomans T, Moran GP, Saunders D, Harris D, Aslett M, Barrell JF, Butler G, Citiulo F, et al.. Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans. Genome Res 2009; 19:2231-44; PMID:19745113; http://dx.doi.org/ 10.1101/gr.097501.109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Gutierrez J, Morales P, Gonzalez MA, Quindos G. Candida dubliniensis, a new fungal pathogen. J Basic Microbiol 2002; 42:207-27; PMID:12111748; http://dx.doi.org/ 10.1002/1521-4028(200206)42:3%3c207::AID-JOBM207%3e3.0.CO;2-C [DOI] [PubMed] [Google Scholar]
  • [14].Pujol C, Daniels KJ, Lockhart SR, Srikantha T, Radke JB, Geiger J, Soll DR. The closely related species Candida albicans and Candida dubliniensis can mate. Eukaryot Cell 2004; 3:1015-27; PMID:15302834; http://dx.doi.org/ 10.1128/EC.3.4.1015-1027.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Virulence are provided here courtesy of Taylor & Francis

RESOURCES